vs
雅培（ABT）与SELECT MEDICAL HOLDINGS CORP（SEM）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是SELECT MEDICAL HOLDINGS CORP的8.2倍（$11.5B vs $1.4B）。雅培净利率更高（15.5% vs 1.4%，领先14.1%）。SELECT MEDICAL HOLDINGS CORP同比增速更快（6.4% vs 4.4%）。雅培自由现金流更多（$2.6B vs $5.2M）。过去两年雅培的营收复合增速更高（7.2% vs 2.8%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
ABT vs SEM — 直观对比
营收规模更大
ABT
是对方的8.2倍
$1.4B
营收增速更快
SEM
高出2.0%
4.4%
净利率更高
ABT
高出14.1%
1.4%
自由现金流更多
ABT
多$2.6B
$5.2M
两年增速更快
ABT
近两年复合增速
2.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $1.4B |
| 净利润 | $1.8B | $20.2M |
| 毛利率 | 57.0% | — |
| 营业利润率 | 19.6% | 4.6% |
| 净利率 | 15.5% | 1.4% |
| 营收同比 | 4.4% | 6.4% |
| 净利润同比 | -80.8% | 225.7% |
| 每股收益（稀释后） | $1.01 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTSEM
| Q4 25 | $11.5B | $1.4B | ||
| Q3 25 | $11.4B | $1.4B | ||
| Q2 25 | $11.1B | $1.3B | ||
| Q1 25 | $10.4B | $1.4B | ||
| Q4 24 | $11.0B | $1.3B | ||
| Q3 24 | $10.6B | $1.3B | ||
| Q2 24 | $10.4B | $1.3B | ||
| Q1 24 | $10.0B | $1.3B |
净利润ABTSEM
| Q4 25 | $1.8B | $20.2M | ||
| Q3 25 | $1.6B | $28.8M | ||
| Q2 25 | $1.8B | $40.6M | ||
| Q1 25 | $1.3B | $56.7M | ||
| Q4 24 | $9.2B | $-16.1M | ||
| Q3 24 | $1.6B | $55.6M | ||
| Q2 24 | $1.3B | $77.6M | ||
| Q1 24 | $1.2B | $96.9M |
毛利率ABTSEM
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | 55.2% | — |
营业利润率ABTSEM
| Q4 25 | 19.6% | 4.6% | ||
| Q3 25 | 18.1% | 5.4% | ||
| Q2 25 | 18.4% | 6.5% | ||
| Q1 25 | 16.3% | 8.3% | ||
| Q4 24 | 17.4% | 1.6% | ||
| Q3 24 | 17.5% | 4.3% | ||
| Q2 24 | 16.1% | 5.8% | ||
| Q1 24 | 13.9% | 9.0% |
净利率ABTSEM
| Q4 25 | 15.5% | 1.4% | ||
| Q3 25 | 14.5% | 2.1% | ||
| Q2 25 | 16.0% | 3.0% | ||
| Q1 25 | 12.8% | 4.2% | ||
| Q4 24 | 84.1% | -1.2% | ||
| Q3 24 | 15.5% | 4.4% | ||
| Q2 24 | 12.5% | 6.1% | ||
| Q1 24 | 12.3% | 7.3% |
每股收益（稀释后）ABTSEM
| Q4 25 | $1.01 | $0.17 | ||
| Q3 25 | $0.94 | $0.23 | ||
| Q2 25 | $1.01 | $0.32 | ||
| Q1 25 | $0.76 | $0.44 | ||
| Q4 24 | $5.26 | $-0.12 | ||
| Q3 24 | $0.94 | $0.43 | ||
| Q2 24 | $0.74 | $0.60 | ||
| Q1 24 | $0.70 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $26.5M |
| 总债务越低越好 | $12.9B | $1.8B |
| 股东权益账面价值 | $52.1B | $1.7B |
| 总资产 | $86.7B | $5.9B |
| 负债/权益比越低杠杆越低 | 0.25× | 1.06× |
8季度趋势，按日历期对齐
现金及短期投资ABTSEM
| Q4 25 | $8.9B | $26.5M | ||
| Q3 25 | $7.7B | $60.1M | ||
| Q2 25 | $7.3B | $52.3M | ||
| Q1 25 | $6.8B | $53.2M | ||
| Q4 24 | $8.0B | $59.7M | ||
| Q3 24 | $7.8B | $191.5M | ||
| Q2 24 | $7.2B | $111.2M | ||
| Q1 24 | $6.7B | $92.6M |
总债务ABTSEM
| Q4 25 | $12.9B | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | $14.1B | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
股东权益ABTSEM
| Q4 25 | $52.1B | $1.7B | ||
| Q3 25 | $51.0B | $1.7B | ||
| Q2 25 | $50.6B | $1.7B | ||
| Q1 25 | $48.8B | $1.7B | ||
| Q4 24 | $47.7B | $1.7B | ||
| Q3 24 | $39.8B | $1.9B | ||
| Q2 24 | $39.3B | $1.4B | ||
| Q1 24 | $38.8B | $1.4B |
总资产ABTSEM
| Q4 25 | $86.7B | $5.9B | ||
| Q3 25 | $84.2B | $5.7B | ||
| Q2 25 | $84.0B | $5.7B | ||
| Q1 25 | $81.4B | $5.7B | ||
| Q4 24 | $81.4B | $5.6B | ||
| Q3 24 | $74.4B | $8.0B | ||
| Q2 24 | $73.0B | $7.9B | ||
| Q1 24 | $72.5B | $7.9B |
负债/权益比ABTSEM
| Q4 25 | 0.25× | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | 0.30× | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $64.3M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $5.2M |
| 自由现金流率自由现金流/营收 | 22.9% | 0.4% |
| 资本支出强度资本支出/营收 | 6.0% | 4.2% |
| 现金转化率经营现金流/净利润 | 1.87× | 3.19× |
| 过去12个月自由现金流最近4个季度 | $7.4B | $117.2M |
8季度趋势，按日历期对齐
经营现金流ABTSEM
| Q4 25 | $3.3B | $64.3M | ||
| Q3 25 | $2.8B | $175.3M | ||
| Q2 25 | $2.0B | $110.3M | ||
| Q1 25 | $1.4B | $-3.5M | ||
| Q4 24 | $2.9B | $125.4M | ||
| Q3 24 | $2.7B | $181.0M | ||
| Q2 24 | $2.0B | $278.2M | ||
| Q1 24 | $1.0B | $-66.7M |
自由现金流ABTSEM
| Q4 25 | $2.6B | $5.2M | ||
| Q3 25 | $2.3B | $122.2M | ||
| Q2 25 | $1.5B | $45.6M | ||
| Q1 25 | $933.0M | $-55.8M | ||
| Q4 24 | $2.1B | $62.0M | ||
| Q3 24 | $2.1B | $130.3M | ||
| Q2 24 | $1.4B | $222.6M | ||
| Q1 24 | $627.0M | $-119.2M |
自由现金流率ABTSEM
| Q4 25 | 22.9% | 0.4% | ||
| Q3 25 | 20.2% | 9.0% | ||
| Q2 25 | 13.9% | 3.4% | ||
| Q1 25 | 9.0% | -4.1% | ||
| Q4 24 | 19.6% | 4.7% | ||
| Q3 24 | 20.2% | 10.2% | ||
| Q2 24 | 13.8% | 17.4% | ||
| Q1 24 | 6.3% | -9.0% |
资本支出强度ABTSEM
| Q4 25 | 6.0% | 4.2% | ||
| Q3 25 | 4.4% | 3.9% | ||
| Q2 25 | 4.5% | 4.8% | ||
| Q1 25 | 4.7% | 3.9% | ||
| Q4 24 | 6.6% | 4.8% | ||
| Q3 24 | 5.2% | 4.0% | ||
| Q2 24 | 5.1% | 4.3% | ||
| Q1 24 | 4.0% | 4.0% |
现金转化率ABTSEM
| Q4 25 | 1.87× | 3.19× | ||
| Q3 25 | 1.70× | 6.09× | ||
| Q2 25 | 1.15× | 2.72× | ||
| Q1 25 | 1.07× | -0.06× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 1.64× | 3.25× | ||
| Q2 24 | 1.51× | 3.59× | ||
| Q1 24 | 0.84× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
